| Spirig HealthCare AG - Bosentan Spirig HC 125 mg, Filmtabletten | | 69790 | | 02 | | Bosentan Spirig HC 125 mg | | Filmtabletten | | C02KX01 | | Bosentan | | 21.10.2025 | | |
| | Composition | | Filmtablette: bosentanum 125 mg ut bosentanum monohydricum 129.08 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium max. 0.32 mg, povidonum K 30, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Bosentan | 125 mg | Filmtablette |
| | BAG: Principe actif | Concentr. |
|---|
| Bosentan | 125 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Talcum | | | | Triacetinum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 56 | 659.06 | 743.70 | B | LS | Non |
|
|
